{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T13:09:10Z","timestamp":1697288950973},"reference-count":39,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T00:00:00Z","timestamp":1224720000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Japanese Society for Dialysis Therapy (JSDT) released the <jats:italic>Guidelines for the Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients<\/jats:italic> (JSDT guidelines), which set target ranges for calcium (8.4\u201310.0\u2003mg\/dL), phosphorus (3.5\u20136.0\u2003mg\/dL) and intact parathyroid hormone (PTH) (60\u2013180\u2003pg\/mL); however, achieving the guideline targets is difficult and challenging. In this post\u2010hoc analysis, we evaluate the impact of cinacalcet on the achievement of the JSDT targets. After a treatment period of 14 weeks, 26% of the cinacalcet group achieved intact PTH levels within the target ranges (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001, compared with the control group). A significantly greater proportion achieved the targets for calcium and phosphorus, as compared with control patients (65% vs. 45%, <jats:italic>P<\/jats:italic>\u2003=\u20030.015; 68% vs. 47%, <jats:italic>P<\/jats:italic>\u2003=\u20030.009, respectively). The proportion of patients in whom serum calcium and phosphorus were controlled to within the target ranges increased from 21% at baseline to 44% (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). The combined targets of three parameters were achieved by 17% of cinacalcet\u2010treated patients, while none of the control patients achieved these parameters simultaneously (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Cinacalcet treatment also efficaciously reduced elevated serum calcium and phosphorus levels. Even in patients with baseline intact PTH levels &gt;500\u2003pg\/mL, where parathyroidectomy has been recommended in the JSDT guidelines, 20% of the cinacalcet group achieved the target intact PTH levels. Longer\u2010term cinacalcet treatment aimed at the JSDT targets may lead to further reductions in PTH secretion. Further studies are required to examine the potential benefit of cinacalcet and to revise the current guidelines relating to adequate use of cinacalcet.<\/jats:p>","DOI":"10.1111\/j.1744-9987.2008.00631.x","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T09:53:43Z","timestamp":1245664423000},"source":"Crossref","is-referenced-by-count":15,"title":["Impact of Cinacalcet Hydrochloride on the Achievement of the Japanese Society for Dialysis Therapy (JSDT) Guideline Targets: A post\u2010hoc Analysis of the KRN1493 Study"],"prefix":"10.1111","volume":"12","author":[{"given":"Hirotaka","family":"Komaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,23]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.07304.x"},{"key":"e_1_2_9_3_2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke TB","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422003"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000133041.27682.A2"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001514"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00540.x"},{"key":"e_1_2_9_8_2","unstructured":"Japanese Society for Dialysis Therapy.Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.Ther Apher Dial(in press)."},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00518.x"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00539.x"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.4040"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:10:2:97"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00183.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman WG","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000050224.03126.AD"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031633"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004060512"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67139.x"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl840"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03591006"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00596.x"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm534"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2008.00556.x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh966"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80010-X"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04381206"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116720"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.4.1598"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001594"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<78::AID-SSU3>3.0.CO;2-Z"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00489.x"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0842"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn058"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00500705"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl560"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl774"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.03.009"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2007.00523.x"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm172"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.2008.00631.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.2008.00631.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T21:48:52Z","timestamp":1694468932000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.2008.00631.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":39,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1744-9987.2008.00631.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.2008.00631.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}